Molecular subtypes and individualized treatment of breast cancer
Xu, B.-h.; Zhang, P.
Zhonghua Zhong Liu Za Zhi 32(9): 641-644
2010
ISSN/ISBN: 0253-3766 PMID: 21122374 Document Number: 642726
Document emailed within 1 workday
Related Documents
Khakimov, G.A.; Shayusupov, N.R.; Miryusupova, G.F. 2015: Molecular-biological subtypes of breast cancer in the Republic of Uzbekistan Voprosy Onkologii 61(6): 1018-10202016: Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes Experimental Oncology 38(2): 122-127
Zhang, H.-M.; Zhang, B.-N.; Xuan, L.-X.; Zhao, P. 2009: Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes Zhonghua Zhong Liu Za Zhi 31(6): 447-451
Mehdi, I.; Monem, A.A.; Al Bahrani, B.; Ramadhan, F.A. 2014: Breast cancer molecular subtypes in oman: correlation with age, histology, and stage distribution - analysis of 542 cases Gulf Journal of Oncology 1(15): 38-48
Mimoto, R.; Kobayashi, T. 2012: Individualized treatment of breast cancer chemotherapy Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 7): 601-605
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Bethea, T.N.; Rosenberg, L.; Hong, C-Chen.; Troester, M.A.; Lunetta, K.L.; Bandera, E.V.; Schedin, P.; Kolonel, L.N.; Olshan, A.F.; Ambrosone, C.B.; Palmer, J.R. 2015: A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium Breast cancer research: BCR 17: 22
Demir, H.; Turna, H.; Can, G.; Ilvan, S. 2010: Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression Journal of BUON: Official Journal of the Balkan Union of Oncology 15(4): 774-782
Chen, Z.Y.; Wang, X.; Wu, T.; Liu, Y.C.; Wang, P.Y. 2017: Progress of molecular subtypes of colorectal cancer Zhonghua Zhong Liu Za Zhi 39(9): 641-645
Ormenisan, C.; Kubik, M.; Legrand, S.; Kraemer, D.; Smotherman, C.; Masood, S. 2015: The potential of ki67 and p53 assessment in development of individualized targeted therapy in breast cancer patients Pathologica 107(3-4): 177-180
Yuan, Z.-y.; Wang, S.-s.; Zhu, M.-q.; Zheng, L.; Luo, W.-b.; Zhou, Z.-m.; Guan, Z.-z. 2008: Clinical characteristics and prognosis of different subtypes of breast cancer Zhonghua Zhong Liu Za Zhi 30(6): 456-461
Horwitz, K.B. 1992: The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocrine Reviews 13(2): 146-163
Chekhun, V.F.; Zhylchuk, V.E.; Lukyanova, N.Y.; Vorontsova, A.L.; Kudryavets, Y.I. 2009: Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients Experimental Oncology 31(2): 123-124
Hoon, D.S.; Bernet, L.; Cano, R.; Viale, G. 2014: Molecular analysis of sentinel lymph nodes and search for molecular signatures of the metastatic potential of breast cancer Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 58(2): 180-192
Ma, H.; Wang, Y.; Sullivan-Halley, J.; Weiss, L.; Marchbanks, P.A.; Spirtas, R.; Ursin, G.; Burkman, R.T.; Simon, M.S.; Malone, K.E.; Strom, B.L.; McDonald, J.A.; Press, M.F.; Bernstein, L. 2010: Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study Cancer Research 70(2): 575-587
Kos, T.; Aksoy, S.; Sendur, M.A.N.; Arik, Z.; Civelek, B.; Kandemir, N.; Ozdemir, N.Y.; Zengin, N.; Altundag, K. 2013: Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes Journal of BUON: Official Journal of the Balkan Union of Oncology 18(3): 608-613
Andersen, J.; Nielsen, M.; Christensen, L.; Ottesen, G.L.; Blichert-Toft, M. 1987: The significance of the frequency and occurrence of breast cancer for treatment. Essential aspects of new Danish studies of the natural history of breast cancer Acta Chirurgica Belgica 87(2): 103-107
Thomsen, K. 1987: Changes in the therapy of operable breast cancer. Treatment of small breast cancer and preinvasive stages Fortschritte der Medizin 105(22): 425-428
Wahner-Roedler, D.L.; Petersen, I.A. 2004: Risk of breast cancer and breast cancer characteristics in women after treatment for Hodgkin lymphoma Drugs of Today 40(10): 865-879
Rintasyöpäryhmä ry, S. 1997: Recommended treatment guideline for breast cancer. Finnish Breast Cancer Group Duodecim; Laaketieteellinen Aikakauskirja 113(22): 2341-2348